Novo Nordisk Investors Eye Alzheimer’s Trial for Glimmer of Hope

After another dismal quarter for Novo Nordisk A/S shares, investors are looking to an experimental treatment of the most common form of dementia to help spark a revival....

Redirecting to full article...